OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
13.64
+0.99 (7.83%)
At close: Jun 27, 2025, 4:00 PM
13.70
+0.06 (0.44%)
After-hours: Jun 27, 2025, 6:34 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $252.27 million as of June 27, 2025. Its market cap has increased by 21.64% in one year.
Market Cap
252.27M
Enterprise Value
268.50M
1-Year Change
21.64%
Ranking
Category
Stock Price
$13.64
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $252.27M, an increase of 637.64%. That is a compound annual growth rate of 32.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 252.30M | 181.90% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.37B |
| Johnson & Johnson | 367.38B |
| AbbVie | 329.61B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.42B |
| Abbott Laboratories | 232.46B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |